Viewing Study NCT02339558

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-03-01 @ 6:01 AM
Study NCT ID: NCT02339558
Status: COMPLETED
Last Update Posted: 2019-09-13
First Post: 2015-01-12
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Nonkeratinizing Carcinoma View
None Recurrent Nasopharynx Carcinoma View
None Stage III Nasopharyngeal Carcinoma AJCC v7 View
None Stage IV Nasopharyngeal Carcinoma AJCC v7 View
None Stage IVA Nasopharyngeal Carcinoma AJCC v7 View
None Stage IVB Nasopharyngeal Carcinoma AJCC v7 View
None Stage IVC Nasopharyngeal Carcinoma AJCC v7 View
Keywords: